Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - BioRestorative Therapies, Inc. | v434828_ex32.htm |
| EX-31.1 - EXHIBIT 31.1 - BioRestorative Therapies, Inc. | v434828_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - BioRestorative Therapies, Inc. | v434828_ex31-2.htm |
| EX-10.20 - EXHIBIT 10.20 - BioRestorative Therapies, Inc. | v434828_ex10-20.htm |
| EX-10.65 - EXHIBIT 10.65 - BioRestorative Therapies, Inc. | v434828_ex10-65.htm |
| EX-10.66 - EXHIBIT 10.66 - BioRestorative Therapies, Inc. | v434828_ex10-66.htm |
| EX-10.61 - EXHIBIT 10.61 - BioRestorative Therapies, Inc. | v434828_ex10-61.htm |
| 10-K - FORM 10-K - BioRestorative Therapies, Inc. | v434828_10k.htm |
| EX-10.64 - EXHIBIT 10.64 - BioRestorative Therapies, Inc. | v434828_ex10-64.htm |
Exhibit 23
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of BioRestorative Therapies, Inc. (the “Company”) on Form S-8 (File No. 333-196299) and Form S-8 (File No. 333-203310) of our report dated March 30, 2016, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of BioRestorative Therapies, Inc. and Subsidiaries as of December 31, 2015 and 2014 and for the years then ended, which report is included in this Annual Report on Form 10-K of BioRestorative Therapies, Inc. for the year ended December 31, 2015.
/s/ Marcum LLP
Marcum LLP
New York, NY
March 30, 2016